1. Home
  2. EHTH vs FATE Comparison

EHTH vs FATE Comparison

Compare EHTH & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EHTH
  • FATE
  • Stock Information
  • Founded
  • EHTH 1997
  • FATE 2007
  • Country
  • EHTH United States
  • FATE United States
  • Employees
  • EHTH N/A
  • FATE N/A
  • Industry
  • EHTH Specialty Insurers
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • EHTH Finance
  • FATE Health Care
  • Exchange
  • EHTH Nasdaq
  • FATE Nasdaq
  • Market Cap
  • EHTH 105.1M
  • FATE 116.5M
  • IPO Year
  • EHTH 2006
  • FATE 2013
  • Fundamental
  • Price
  • EHTH $3.43
  • FATE $1.04
  • Analyst Decision
  • EHTH Hold
  • FATE Buy
  • Analyst Count
  • EHTH 3
  • FATE 7
  • Target Price
  • EHTH $9.00
  • FATE $3.92
  • AVG Volume (30 Days)
  • EHTH 378.8K
  • FATE 2.1M
  • Earning Date
  • EHTH 11-05-2025
  • FATE 11-13-2025
  • Dividend Yield
  • EHTH N/A
  • FATE N/A
  • EPS Growth
  • EHTH N/A
  • FATE N/A
  • EPS
  • EHTH 0.04
  • FATE N/A
  • Revenue
  • EHTH $542,951,000.00
  • FATE $7,137,000.00
  • Revenue This Year
  • EHTH $4.88
  • FATE N/A
  • Revenue Next Year
  • EHTH $3.42
  • FATE N/A
  • P/E Ratio
  • EHTH $79.32
  • FATE N/A
  • Revenue Growth
  • EHTH 16.79
  • FATE N/A
  • 52 Week Low
  • EHTH $3.18
  • FATE $0.66
  • 52 Week High
  • EHTH $11.36
  • FATE $3.43
  • Technical
  • Relative Strength Index (RSI)
  • EHTH 34.44
  • FATE 41.08
  • Support Level
  • EHTH $3.30
  • FATE $0.95
  • Resistance Level
  • EHTH $3.97
  • FATE $1.11
  • Average True Range (ATR)
  • EHTH 0.33
  • FATE 0.10
  • MACD
  • EHTH -0.12
  • FATE -0.01
  • Stochastic Oscillator
  • EHTH 8.91
  • FATE 25.71

About EHTH eHealth Inc.

eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: